Early HPV Vaccine Implementation and Uptake in Five Nigerian States

A mixed-methods study document analyzing the early rollout of the Human Papillomavirus (HPV) vaccine in Nigeria. The research, authored by Gbemisola T. Olubayo, assessed vaccine availability and uptake across 52 health facilities in five states over a 4-month period in 2023. It includes quantitative data on vaccine doses and qualitative interview data exploring contextual determinants of delivery and acceptance.

Use Cases

• Analyzing geographic disparities in vaccine availability based on state-level comparisons mentioned in the results.
• Studying the relationship between community outreach, trust in healthcare workers, and vaccine uptake as described in the qualitative themes.
• Modeling the impact of structural constraints and sociocultural barriers on public health intervention equity as discussed in the conclusion.

Strengths

• Includes data from 52 health facilities across five Nigerian states (Oyo, Jigawa, Kano, Lagos, Rivers).
• Combines quantitative metrics (e.g., 0 to 308 doses per facility) with qualitative interview data for explanatory depth.
• Released under a permissive CC-BY-4.0 license, allowing for broad reuse and adaptation.

Limitations

• The underlying data tables are embedded within a DOCX document; column-level documentation and raw data are not separately structured.
• Row count for the quantitative data is unknown, which may limit suitability assessment for statistical modeling.
• The 38.7 KB file size suggests the dataset's quantitative component is very limited in scale.

Provenance

Source

figshare, authored by Gbemisola T. Olubayo.

Collection Method

Sequential explanatory mixed-methods design involving monthly facility visits, register reviews, and in-depth interviews with healthcare workers.

Time Range

Covers a 4-month period in 2023 following Nigeria's HPV vaccine introduction.

Freshness

Last updated 2026-06-02 15:40:18; freshness should be verified.

Geography

Five Nigerian states: Oyo, Jigawa, Kano, Lagos, and Rivers.